Read + Share
Amedeo Smart
Independent Medical Education
Teke ME, Rossi AJ, Hernandez JM, Gastman B, et al. Pembrolizumab Compared with Standard-of-Care Observation in Treating Patients with Completely Resected Stage I-III Merkel Cell Cancer (STAMP). Ann Surg Oncol 2022;29:3379-3380.PMID: 35258767
Email
LinkedIn
Facebook
Twitter
Privacy Policy